TNFRSF17 and plasma cell myeloma: Conversely, BCMA is predominantly expressed in specific subsets at the late stages of B cell differentiation, including plasma cells, plasmablasts, certain memory B cells, and malignant B cells (e.g., malignant plasma cells in multiple myeloma) (101).